Cargando…

Use of daptomycin and vancomycin in blood stream infections with PDR Acinetobacter Baumanii

Detalles Bibliográficos
Autores principales:	Alexandropoulos, P, Georgiou, S, Chantziara, V, Tsimogianni, A, Vassi, A, Lagiou, F, Miha, G, Chinou, E, Skotadi, K, Michaloudis, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796177/ http://dx.doi.org/10.1186/2197-425X-3-S1-A407

Ejemplares similares

Intrathecal administration of colistin, vancomycin and amikacin for central nervous system infections in ICU neurosurgical patients
por: Alexandropoulos, P, et al.
Publicado: (2015)

An outbreak of Acinetobacter baumanii in an ICU: effectiveness of an extensive infection control program
por: Bonizzoli, M, et al.
Publicado: (2006)

Clinical experiment with the use of colistin for the treatment of multiresistant Acinetobacter baumanii nosocomial infection
por: Safi, L, et al.
Publicado: (2009)

Intrathecal (intraventricular) polymyxin B in the treatment of patients with meningoencephalitis by Acinetobacter baumanii and Pseudomonas aeruginosa
por: Macedo, SK, et al.
Publicado: (2011)

Management of an outbreak of multiresistant Acinetobacter baumanii infection in a surgical intensive care unit
por: Lewejohann, J, et al.
Publicado: (2007)

Ozone fumigation successfully controlled and eradicated multidrug-resistant Acinetobacter baumanii from an intensive care unit
por: Stümpfle, R, et al.
Publicado: (2010)

846. Trends in Acinetobacter baumanii Antibiotic Resistance Rates
por: Caffrey, Aisling, et al.
Publicado: (2020)

1610. Epidemiology and Treatment Heterogeneity in Acinetobacter baumanii Infections
por: Caffrey, Aisling, et al.
Publicado: (2020)

Successful treatment of multicompartmental cerebral ventriculitis caused by Acinetobacter baumanii
por: Mahoney, Dom, et al.
Publicado: (2017)

S33.1 Multidrug-resistant Acinetobacter baumanii and Pseudomonas aeruginosa
Publicado: (2005)

The antibiotic resistance proteome of Acinetobacter baumanii MDR isolate MMC#4
por: Marshall, Dana, et al.
Publicado: (2012)

Minocycline: The second important antimicrobial in multidrug-resistant Acinetobacter baumanii infections
por: Nair, Abhijit S.
Publicado: (2018)

Control of multidrug resistant (MDR) Acinetobacter baumanii outbreak in a pediatric oncology unit by optimizing infection prevention (IP) and control measures
por: Melgar, MA, et al.
Publicado: (2011)

2441. Outcomes of Patients With Vancomycin-Resistant Enterococcus Blood Stream Infections (BSI) Treated With Daptomycin
por: Shimose, Luis A, et al.
Publicado: (2018)

2444. Incidence of Daptomycin Toxicity Among Patients With Vancomycin-Resistant Enterococcus Blood Stream Infections
por: Rios, Maria X Bueno, et al.
Publicado: (2018)

Control and Elimination of Extensively Drug-Resistant Acinetobacter baumanii in an Intensive Care Unit
por: Chamieh, Amanda, et al.
Publicado: (2019)

Prognostic differences between VAP from Acinetobacter baumanii and VAP from other microorganisms
por: Di Bonito, Marianna, et al.
Publicado: (2012)

Fatal Acinetobacter baumanii Necrotizing Fasciitis following Open Reduction Internal Fixation in a Polytrauma Patient
por: Nehme, Alexandre, et al.
Publicado: (2018)

Next-gen sequencing of multi-drug resistant Acinetobacter baumanii at Nashville General Hospital at Meharry
por: Dent, Leon, et al.
Publicado: (2011)

Bloodstream infection with Acinetobacter baumanii in a Plasmodium falciparum positive infant: a case report
por: Akenten, Charity Wiafe, et al.
Publicado: (2021)

Acynetobacter baumanii extremely resistant outbreak control in ICU: a multidisciplinary approach
por: Muñoz, M, et al.
Publicado: (2015)

Emergence of tigecycline & colistin resistant Acinetobacter baumanii in patients with complicated urinary tract infections in north India
por: Taneja, Neelam, et al.
Publicado: (2011)

Association of Single Nucleotide Polymorphisms in Toll-like Receptors with Acinetobacter baumanii Infectionin a Chinese Population
por: HE, Lei, et al.
Publicado: (2016)

Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin
por: Estes, Kerry S, et al.
Publicado: (2010)

Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol
por: Zarogoulidis, Paul, et al.
Publicado: (2014)

Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria
por: Blaskovich, Mark A. T., et al.
Publicado: (2018)

The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas
por: Pertel, P E, et al.
Publicado: (2009)

1539. Dalbavancin, Vancomycin, and Daptomycin Alone and in Combination with Cefazolin Against Vancomycin Intermediate-Resistant (VISA) and Daptomycin Non-Susceptible (DNS) Staphylococcus aureus
por: Abdul-Mutakabbir, Jacinda, et al.
Publicado: (2019)

Distribution of Carbapenemase Genes among Carbapenem-Non-Susceptible Acinetobacter baumanii Blood Isolates in Indonesia: A Multicenter Study
por: Anggraini, Dewi, et al.
Publicado: (2022)

Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia
por: Narayanan, Navaneeth, et al.
Publicado: (2019)

Molecular characterization and genetic relatedness of clinically Acinetobacter baumanii isolates conferring increased resistance to the first and second generations of tetracyclines in Iran
por: Meshkat, Zahra, et al.
Publicado: (2017)

New Mutations in cls Lead to Daptomycin Resistance in a Clinical Vancomycin- and Daptomycin-Resistant Enterococcus faecium Strain
por: Li, Weiwei, et al.
Publicado: (2022)

Implementation of WHO multimodal hand hygiene (HH) improvement strategy to reduce healthcare-associated infections (HAI) and VAP (ventilator-associated pneumonia) caused by multi-drug resistant acinetobacter baumanii (MDRAB) at Siloam Hospitals Surabaya (SHBS), Indonesia
por: Mustikawati, B Indah, et al.
Publicado: (2015)

Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant Staphylococcus aureus Bacteremia—A Meta-Analysis
por: Huang, Chienhsiu, et al.
Publicado: (2022)

Breakthrough daptomycin-, linezolid-, vancomycin-resistant Enterococcus faecium bacteremia during protracted daptomycin therapy: A case report
por: Pincus, Nathan B., et al.
Publicado: (2022)

Designing a Multiplex PCR for Rapid and Accurate Detection of Metallobetalactamases Resistant Genes from Acinetobacter baumaniiIsolates in Tehran City, Iran
por: Mottaghiyan, Zahra, et al.
Publicado: (2023)

In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci
por: Tong, Jiepeng, et al.
Publicado: (2021)

Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs
por: Crompton, Jason A., et al.
Publicado: (2010)

Effect of daptomycin and vancomycin on Staphylococcus epidermidis biofilms: An in vitro assessment using fluorescence in situ hybridization
por: Sutrave, S., et al.
Publicado: (2019)

Imported PER-1 producing Pseudomonas aeruginosa, PER-1 producing Acinetobacter baumanii and VIM-2-producing Pseudomonas aeruginosa strains in Hungary
por: Szabó, Dora, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_6t1aj4kcc6cr0a8dtg3dhr5b12